BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 10605049)

  • 1. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
    Turgeon NA; Iwakoshi NN; Phillips NE; Meyers WC; Welsh RM; Greiner DL; Mordes JP; Rossini AA
    J Surg Res; 2000 Sep; 93(1):63-9. PubMed ID: 10945944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
    Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
    Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
    Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade.
    Gao D; Lunsford KE; Eiring AM; Bumgardner GL
    Am J Transplant; 2004 Jul; 4(7):1061-70. PubMed ID: 15196062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig.
    Pinelli DF; Wagener ME; Liu D; Yamniuk A; Tamura J; Grant S; Larsen CP; Suri A; Nadler SG; Ford ML
    Am J Transplant; 2013 Nov; 13(11):3021-30. PubMed ID: 24007441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulatory blockade induces hyporesponsiveness in T cells that recognize alloantigen via indirect antigen presentation.
    Phillips NE; Greiner DL; Mordes JP; Rossini AA
    Transplantation; 2006 Oct; 82(8):1085-92. PubMed ID: 17060858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.